Oscar Health Unveils New Insurance Plans in New Jersey for 2025
Oscar Health, Inc. (NYSE: OSCR), a leading healthcare technology company, is expanding its presence in New Jersey by offering a wider range of affordable health insurance plans through the ACA marketplace in 2025. This expansion will make Oscar’s personalized healthcare…
Alpha Cognition Reports Q2 and H1 2024 Financial Results and Corporate Update
Alpha Cognition Inc. (NASDAQ: ACOG) (CSE: ACOG), a biopharmaceutical company focused on developing therapies for neurodegenerative diseases, has released its financial results for the second quarter and six months ending September 30, 2024, along with a corporate update. Key Updates:…
Universal Health Services Recognized for Board Diversity by The Forum of Executive Women
Universal Health Services (UHS) (NYSE: UHS) has been named a Champion of Board Diversity by The Forum of Executive Women, the leading women’s organization in the Greater Philadelphia Region. This prestigious recognition honors public companies in the region with at…
Cardinal Health Unveils New Chemistry Lab for R&D
Cardinal Health recently celebrated the grand opening of its new Scientific Services Chemistry Center in Mansfield, Massachusetts. This state-of-the-art, FDA-regulated laboratory spans nearly 26,000 square feet and is designed to accelerate product development, enhance manufacturing efficiency, and ensure top-tier regulatory…
Inside Cardinal Health’s Innovation in Drapes and Gowns
In the fast-paced and high-stakes environment of the operating room (OR), precision and protection are critical. That’s why Cardinal Health’s Surgical Drapes and Gowns team focuses on creating products designed to safeguard both clinicians and patients during medical procedures. Every…
Cardinal Health Adds Two New Strategic Assets to Portfolio
Cardinal Health (NYSE: CAH) announced the signing of definitive agreements to acquire two key companies that align with its growth strategy and will enhance patient care. The acquisitions include a majority stake in GI Alliance (GIA), a leading gastroenterology management…
Meridian Health Plan of Illinois Launches Telehealth for YouthCare Members via Blueberry Pediatrics
Meridian Health Plan of Illinois, a provider of managed care services for children, families, and individuals with complex medical needs, has expanded its telehealth program with Blueberry Pediatrics. Initially launched as a pilot in March 2024, the program will now…
Elation Health Survey: 66% of Primary Care Docs Say AI Reduces Administrative Burden
Elation Health, a clinical-first technology company driving innovation in primary care, today shared the results of its latest survey of 100 primary care physicians (PCPs). The survey provides valuable insights into the adoption and impact of artificial intelligence (AI) in…
Bristol Myers Squibb Gets CHMP Nod for Opdivo + Yervoy in MSI-High Colorectal Cancer
Bristol Myers Squibb (NYSE: BMY) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of Opdivo® (nivolumab) in combination with Yervoy® (ipilimumab) for the first-line…
HCA Healthcare Named Best Employer for Veterans by Military Times for Fifth Year
HCA Healthcare, one of the nation’s leading healthcare providers, has been named a Best for Vets Employer by Military Times for the fifth consecutive year, in recognition of its ongoing efforts to recruit, mentor, and retain U.S. service members. Since…
Vektor Medical’s AI-Powered vMap Achieves 91% Accuracy in Distinguishing Ventricular Tachycardia Types
Vektor Medical, a leader in non-invasive arrhythmia analysis and localization, today announced new data demonstrating the enhanced capabilities of its AI-powered solution, vMap, for improving cardiac arrhythmia treatment. The data, to be presented at the American Heart Association (AHA) Scientific…
Cofactor Genomics Expands OncoPrism Use After National Validation for Lung Cancer Immunotherapy
Cofactor Genomics, Inc., a clinical-stage company focused on bridging the precision medicine gap through RNA decoding, today announced the validation and launch of OncoPrism®-NSCLC, an RNA-based diagnostic test designed to predict response to immune checkpoint inhibitors (ICI) in patients with…